Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic Function
Clinical trial NCT03562117 · COMPLETED
Trial details
- NCT number
- NCT03562117
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-14
- Primary completion
- 2018-12-26
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.